Fresubin 2 kcal Drink: high-calorie oral nutrition for demanding needs
12.06.2026 - 14:20:42 | ad-hoc-news.de
Responsible: ad hoc news Lifestyle & Consumer Desk. Reviewed prior to publication on June 12, 2026 at 2:19:48 PM ET. Details in the imprint.
Fresubin 2 kcal Drink is one of Fresenius Kabi's best-known oral nutritional supplements, positioned as a compact, high-calorie and high-protein liquid feed for people who struggle to meet their nutritional needs with normal food alone. The ready-to-drink formula delivers about 2.0 kcal per milliliter, so a standard 200 ml bottle provides roughly 400 kcal, alongside a balanced mix of protein, fats, carbohydrates, vitamins and minerals. It is marketed for medical use under professional supervision, but it also plays an important role in long-term home nutrition, for example after surgery, during chronic illness, or in phases of age-related malnutrition. While detailed US pack variants may differ from European labels, the core concept of a dense, complete, sip feed is the same, and the product is widely distributed in pharmacies, hospital channels and via online retailers.
What Fresubin 2 kcal Drink is designed to do
Fresubin 2 kcal Drink is a nutritionally complete, high-energy, high-protein oral nutrition supplement intended for patients with or at risk of disease-related malnutrition, especially where fluid intake needs to be limited. According to Fresenius Kabi's product information, each 200 ml bottle typically provides about 400 kcal, around 20 grams of protein and a full micronutrient profile to cover daily requirements when several bottles are consumed per day. That calorie density means patients can cover substantial portions of their daily energy intake with a small volume, which is critical for people with poor appetite, chewing or swallowing difficulties, or increased energy demands due to illness. The formulation is usually gluten-free and lactose-reduced and is suitable for many patients with common food intolerances, though the exact labeling can vary by market and flavor.
The drink is typically prescribed or recommended in hospitals, nursing homes and outpatient care and is classified as a food for special medical purposes, which means it is intended for use under medical supervision rather than as a general fitness shake. Clinicians often use Fresubin 2 kcal Drink as part of nutritional support in oncology, geriatrics, post-operative rehabilitation or chronic conditions such as COPD, where weight loss and muscle wasting are frequent problems. For home use, patients or caregivers are usually instructed to consume one to several bottles per day, depending on individual energy and protein goals, either between meals or as a meal replacement where needed. The energy density and balanced nutrient content are designed so that 3 bottles per day can cover a large portion of daily needs in adults, which helps stabilize body weight and support recovery.
Flavor choice is a practical detail that matters in long-term nutrition and Fresubin 2 kcal Drink is available in multiple sweet-oriented flavors such as vanilla, chocolate, cappuccino and fruit variants, depending on the country. This variety is meant to help maintain acceptance over weeks or months of use, as monotony is a common reason patients reduce intake. The drink is usually ready to use and tastes better when served chilled; many patient guides recommend shaking the bottle well before opening and sipping slowly over about 30 minutes to minimize discomfort or feelings of fullness. Some dietitians suggest using a straw or alternating flavors during the day to encourage consistent consumption.
In its product documents, Fresenius Kabi typically emphasizes that Fresubin 2 kcal Drink is not suitable for children under a specified age (often under 3 years) and should not be used in patients with certain metabolic disorders, such as severe liver or kidney failure without individual assessment, or in situations where enteral nutrition is contraindicated. The product is also not intended for use as parenteral nutrition, since it is formulated for oral or tube feeding via the gastrointestinal tract. As with comparable medical nutrition drinks, professional monitoring is recommended to adjust dosage, watch for refeeding issues in severely malnourished patients, and integrate the drink into a broader meal plan that takes into account any fluid restrictions, blood sugar control or other disease-specific constraints.
How it fits into Fresenius Kabi's nutrition portfolio and availability
Fresubin 2 kcal Drink sits in the middle of Fresenius Kabi's broad enteral nutrition range, which spans standard formulas, fiber-enriched variants, specialized disease-focused feeds and tube-feeding solutions. Compared with lower-density options such as some 1.0 or 1.5 kcal per ml products, the 2 kcal formulation is aimed specifically at situations where patients need more energy and protein in a smaller volume, or where clinicians want to reduce the total fluid load while still covering nutritional needs. Within the Fresubin line, it often appears alongside products like Fresubin Energy or Fresubin Original, giving healthcare professionals a choice depending on each patient's tolerance and calorie goals. This layered portfolio allows Fresenius Kabi to address a wide range of indications, from moderate supplementary feeding to intensive nutrition support in severely malnourished individuals.
Fresenius Kabi positions Fresubin-branded oral nutritional supplements as a core pillar of its clinical nutrition business, which is one of the company's central segments alongside infusion therapy and generic injectable drugs. In its corporate materials, the company highlights clinical nutrition as a key contributor to revenue and as an area with structural growth drivers such as aging populations, higher prevalence of chronic diseases and greater awareness of malnutrition in hospitals and long-term care. Products like Fresubin 2 kcal Drink are used in many countries across Europe and other regions; for the US market, Fresenius Kabi offers a portfolio of oral nutrition and tube feeds that follows comparable concepts, although naming and regulatory classification may differ. Distribution channels typically include hospital and institutional purchasing, specialty pharmacies and medical supply retailers, and online platforms, making it possible for patients to continue therapy at home after discharge.
For consumers or caregivers in the US, comparable Fresenius Kabi medical nutrition products can often be sourced via hospital-affiliated pharmacies, durable medical equipment suppliers, or mainstream online retailers that carry clinical nutrition items, sometimes requiring a prescription or professional recommendation depending on reimbursement rules. Pricing in US dollars may vary significantly by channel and insurance coverage, and list prices can differ from pharmacy dispensing prices. Because Fresubin 2 kcal Drink is a medical nutrition product rather than a standard grocery drink, buyers should check product labeling carefully for the intended indication, age range and any allergens such as milk protein or soy, and follow the guidance of physicians or dietitians when integrating it into daily nutrition.
For Fresenius SE & Co. KGaA, the Fresubin range underscores the strategic importance of clinical nutrition as a recurring-revenue business, complementing its hospital services and pharmaceutical activities. Shares of Fresenius SE & Co. KGaA (DE0005785604, ticker FRE) last traded around 37.25 euros on Xetra on June 11, 2026, according to exchange data.
Snapshot: Fresubin 2 kcal Drink
- Product: Fresubin 2 kcal Drink
- Manufacturer: Fresenius SE & Co. KGaA
- Category: Lifestyle & consumer oral medical nutrition
- Launch date: Longstanding product line, available in multiple markets for several years (exact initial launch year not specified)
- MSRP / Price: Pricing varies by channel and prescription status; typical online listings show multi-bottle packs with per-bottle prices often in the range of a few US dollars before insurance, depending on retailer and configuration
- Availability: Distributed via hospitals, pharmacies, medical supply retailers and online channels in many countries; comparable Fresenius Kabi medical nutrition products are available through US clinical and retail channels
- Target audience: Adults and older patients with or at risk of disease-related malnutrition, especially with elevated energy needs or fluid restrictions, under medical supervision
- Key feature / USP: High-energy, high-protein, nutritionally complete 2 kcal per ml oral nutrition in a compact 200 ml bottle for efficient calorie intake
More background on Fresenius SE & Co. KGaA
Readers who follow Fresubin 2 kcal Drink often also look for broader context on Fresenius SE & Co. KGaA and its clinical nutrition and healthcare portfolio.
More Fresenius SE & Co. KGaA news Investor RelationsThis article was created with a.i. assistance and editorially reviewed. Product information is provided without warranty; prices and availability may change at any time. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.
